LLY Sep 2024 420.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 04:44PM EDT. Market open.
| Previous Close | 334.77 |
| Open | N/A |
| Bid | 356.00 |
| Ask | 364.80 |
| Strike | 420.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 334.77 - 334.77 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 5 |
Zacks3 Stocks to Buy Following Positive Earnings Results
All three of these companies saw buyers step up post-earnings, reflecting the positivity of their results.
Zacks3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.
Barrons.comRoche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
The results, from a small trial of a drug called CT-388, hint that Roche could be a serious player in the weight-loss market in coming years.
© 2024 Yahoo. All rights reserved.